| Voluntary running suppresses tumor growth through epinephrine-and IL-6-dependent NK cell mobilization and redistribution L Pedersen, M Idorn, GH Olofsson, B Lauenborg, I Nookaew, RH Hansen, ... Cell metabolism 23 (3), 554-562, 2016 | 794 | 2016 |
| Actively personalized vaccination trial for newly diagnosed glioblastoma N Hilf, S Kuttruff-Coqui, K Frenzel, V Bukur, S Stevanović, ... Nature 565 (7738), 240-245, 2019 | 761 | 2019 |
| SARS-CoV2-mediated suppression of NRF2-signaling reveals potent antiviral and anti-inflammatory activity of 4-octyl-itaconate and dimethyl fumarate D Olagnier, E Farahani, J Thyrsted, J Blay-Cadanet, A Herengt, M Idorn, ... Nature communications 11 (1), 4938, 2020 | 356 | 2020 |
| Exercise-dependent regulation of NK cells in cancer protection M Idorn, P Hojman Trends in molecular medicine 22 (7), 565-577, 2016 | 215 | 2016 |
| Correlation between frequencies of blood monocytic myeloid-derived suppressor cells, regulatory T cells and negative prognostic markers in patients with castration-resistant … M Idorn, T Køllgaard, P Kongsted, L Sengeløv, P thor Straten Cancer immunology, immunotherapy 63, 1177-1187, 2014 | 186 | 2014 |
| Exercise and cancer: from “healthy” to “therapeutic”? M Idorn, P thor Straten Cancer Immunology, Immunotherapy 66, 667-671, 2017 | 168 | 2017 |
| Capsid-like particles decorated with the SARS-CoV-2 receptor-binding domain elicit strong virus neutralization activity C Fougeroux, L Goksøyr, M Idorn, V Soroka, SK Myeni, R Dagil, ... Nature Communications 12 (1), 324, 2021 | 95 | 2021 |
| Chemokine receptor engineering of T cells with CXCR2 improves homing towards subcutaneous human melanomas in xenograft mouse model M Idorn, SK Skadborg, L Kellermann, HR Halldórsdóttir, ... Oncoimmunology 7 (8), e1450715, 2018 | 69 | 2018 |
| A serum-stable RNA aptamer specific for SARS-CoV-2 neutralizes viral entry J Valero, L Civit, DM Dupont, D Selnihhin, LS Reinert, M Idorn, BA Israels, ... Proceedings of the National Academy of Sciences 118 (50), e2112942118, 2021 | 67 | 2021 |
| TLR2 and TLR7 mediate distinct immunopathological and antiviral plasmacytoid dendritic cell responses to SARS‐CoV‐2 infection RM van der Sluis, LB Cham, A Gris‐Oliver, KR Gammelgaard, ... The EMBO journal 41 (10), e109622, 2022 | 62 | 2022 |
| Acquired immune resistance follows complete tumor regression without loss of target antigens or IFNγ signaling M Donia, K Harbst, M van Buuren, P Kvistborg, MF Lindberg, R Andersen, ... Cancer Research 77 (17), 4562-4566, 2017 | 43 | 2017 |
| Improved migration of tumor ascites lymphocytes to ovarian cancer microenvironment by CXCR2 transduction M Idorn, M Olsen, HR Halldórsdóttir, SK Skadborg, M Pedersen, ... Oncoimmunology 7 (4), e1412029, 2018 | 42 | 2018 |
| SARS-CoV-2 neutralizing antibody responses towards full-length spike protein and the receptor-binding domain R Bayarri-Olmos, M Idorn, A Rosbjerg, L Pérez-Alós, CB Hansen, ... The Journal of Immunology 207 (3), 878-887, 2021 | 37 | 2021 |
| The alpha/B. 1.1. 7 SARS-CoV-2 variant exhibits significantly higher affinity for ACE-2 and requires lower inoculation doses to cause disease in K18-hACE2 mice R Bayarri-Olmos, LB Johnsen, M Idorn, LS Reinert, A Rosbjerg, S Vang, ... Elife 10, e70002, 2021 | 31 | 2021 |
| High frequency of T cells specific for cryptic epitopes in melanoma patients RS Andersen, SR Andersen, MD Hjortsø, R Lyngaa, M Idorn, TM Køllgård, ... Oncoimmunology 2 (7), e25374, 2013 | 31 | 2013 |
| Clonal expansion of renal cell carcinoma-infiltrating T lymphocytes SP Sittig, T Køllgaard, K Grønbæk, M Idorn, J Hennenlotter, A Stenzl, ... Oncoimmunology 2 (9), e26014, 2013 | 29 | 2013 |
| Human ZBP1 induces cell death‐independent inflammatory signaling via RIPK3 and RIPK1 R Peng, CK Wang, X Wang‐Kan, M Idorn, M Kjær, FY Zhou, BK Fiil, ... EMBO reports 23 (12), e55839, 2022 | 28 | 2022 |
| Chemokine receptors and exercise to tackle the inadequacy of T cell homing to the tumor site M Idorn, P Thor Straten Cells 7 (8), 108, 2018 | 27 | 2018 |
| Exercise oncology and immuno-oncology; a (future) dynamic duo G Holmen Olofsson, AWP Jensen, M Idorn, P thor Straten International Journal of Molecular Sciences 21 (11), 3816, 2020 | 26 | 2020 |
| Vγ9Vδ2 T cells concurrently kill cancer cells and cross-present tumor antigens G Holmen Olofsson, M Idorn, AM Carnaz Simões, P Aehnlich, ... Frontiers in immunology 12, 645131, 2021 | 24 | 2021 |
